Skip to content

Advertisement

Open Peer Review Reports for: Abiraterone acetate plus LHRH therapy versus abiraterone acetate while sparing LHRH therapy in patients with progressive, metastatic and chemotherapy-naïve, castration-resistant prostate cancer (SPARE): study protocol for a randomized controlled trial

Back to article

Pre-publication versions of this article are available by contacting editorial@trialsjournal.com.

Original Submission
15 May 2017 Submitted Original manuscript
31 Aug 2017 Author responded Author comments - Carsten Ohlmann
Resubmission - Version 2
31 Aug 2017 Submitted Manuscript version 2
13 Sep 2017 Author responded Author comments - Carsten Ohlmann
Resubmission - Version 3
13 Sep 2017 Submitted Manuscript version 3
Publishing
14 Sep 2017 Editorially accepted
4 Oct 2017 Article published 10.1186/s13063-017-2195-x

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement